Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01181882 · ClinicalTrials.gov registry record · Phase 2
Fish Oil and Aspirin With Type 2 Diabetes
A Phase 2 study, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT01181882 is a Phase 2 study that has completed, run by University of Rochester. The registered enrollment target is 30 participants.
The verdict
NCT01181882, a Phase 2 study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to understand if omega-3 fatty acids in fish oil enhance the ability of aspirin to reduce the risk of cardiovascular diseases such as heart attack and stroke in those who have diabetes mellitus.
Interventions
- DIETARY_SUPPLEMENT Fish Oil and Aspirin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2010-08 |
| Est. Completion | 2012-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01181882
The ClinicalTrials.gov registry entry for NCT01181882 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fish Oil and Aspirin is the first listed.
NCT01181882 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01181882 about?
NCT01181882 is a clinical study titled "Fish Oil and Aspirin With Type 2 Diabetes". The purpose of this study is to understand if omega-3 fatty acids in fish oil enhance the ability of aspirin to reduce the risk of cardiovascular diseases such as heart attack and stroke in those who have diabetes mellitus.
What is the current status of trial NCT01181882?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2010-08. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01181882?
The interventions under investigation include: Fish Oil and Aspirin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01181882?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.